Join
Live feed
·
PRReleasevia Quantisnow
Rafael Holdings Inc. logo

Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C

ByQuantisnow·Wall Street's wire, on your screen.
RFL· Rafael Holdings Inc.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RFL (Rafael Holdings Inc.) and more on Quantisnow.